Distribution to erythrocytes of Methylphenidate [Bioanalytics]

posted by Ohlbe – France, 2019-01-06 18:07 (858 d 22:52 ago) – Posting: # 19736
Views: 1,397

Dear EKY,

» According to available data that methylphenidate and its metabolites are distributed between plasma (57%) and erythrocytes (43%) in blood.

If I interpret correctly what you wrote, concentrations are comparable in plasma and erythrocytes. So hemolysis will not release massive amounts of the drug or metabolites in plasma, contrary to e.g. ciclosporine.

» Can the respective plasma concentrations from hemolysis samples be fallacious?

Yes, possibly, by other ways. If you are using LC-MS/MS, you may have differences in matrix effects in hemolysed samples, but you are supposed to check for this during method validation. If you are using HPLC/UV, you may get chromatographic interferences. Whatever the method, you may have problems with recovery, or with analyte stability (see for instance this paper).

Regards
Ohlbe

Complete thread:

Activity
 Admin contact
21,460 posts in 4,486 threads, 1,514 registered users;
online 5 (0 registered, 5 guests [including 1 identified bots]).
Forum time: Friday 17:00 UTC (Europe/Vienna)

Art is “I”; science is “we”.    Claude Bernard

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5